Johns Hopkins ABX Guide
Ceftolozane/tazobactam
Ceftolozane/tazobactam is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Ceftolozane/tazobactam is currently on manufacturer backorder. Per communication from Merck, the drug is not expected to be released until early 2022.
- Alternative therapies for MDR Pseudomonas aeruginosashould be considered.
- Complicated intra-abdominal infections (cIAI), used in combination with metronidazole
- Complicated urinary tract infections (cUTI), including pyelonephritis
- Hospital-acquired bacterial and ventilator-associated pneumonia (VAP)
Note: FDA indications for age ≥ 18 yrs
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pseudomonas aeruginosa infections (including some MDR isolates, limited data[6])
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Ceftolozane/tazobactam is currently on manufacturer backorder. Per communication from Merck, the drug is not expected to be released until early 2022.
- Alternative therapies for MDR Pseudomonas aeruginosashould be considered.
- Complicated intra-abdominal infections (cIAI), used in combination with metronidazole
- Complicated urinary tract infections (cUTI), including pyelonephritis
- Hospital-acquired bacterial and ventilator-associated pneumonia (VAP)
Note: FDA indications for age ≥ 18 yrs
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pseudomonas aeruginosa infections (including some MDR isolates, limited data[6])
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 21, 2021
Citation
Dzintars, Kathryn. "Ceftolozane/tazobactam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2021. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540650/all/Ceftolozane_tazobactam.
Dzintars K. Ceftolozane/tazobactam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540650/all/Ceftolozane_tazobactam. Accessed March 24, 2023.
Dzintars, K. (2021). Ceftolozane/tazobactam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540650/all/Ceftolozane_tazobactam
Dzintars K. Ceftolozane/tazobactam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. [cited 2023 March 24]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540650/all/Ceftolozane_tazobactam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftolozane/tazobactam
ID - 540650
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2021/03/21/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540650/all/Ceftolozane_tazobactam
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
